A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer - Schneeweiss, Andreas; Marmé, Frederik; Sinn, Peter (Annals of oncology, 2011)